首页> 外文期刊>Photodermatology, photoimmunology and photomedicine >Aminolaevulinic acid diffusion characteristics in 'in vitro' normal human skin and actinic keratosis: implications for topical photodynamic therapy.
【24h】

Aminolaevulinic acid diffusion characteristics in 'in vitro' normal human skin and actinic keratosis: implications for topical photodynamic therapy.

机译:氨基乙酰丙酸在“体外”正常人皮肤和光化性角化病中的扩散特征:对局部光动力疗法的影响。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: The response rate of aminolaevulinic acid (ALA)-based photodynamic therapy (PDT) in certain subtypes of actinic keratosis (AK), such as hypertrophic and hyperkeratotic lesions, is variable, an effect attributable to a supposed lack of ALA penetration. A detailed and depth-related profile of spatial ALA permeation in AK following drug administration would lead to a greater understanding of concentrations achievable before protoporphyrin IX biosynthesis and subsequent PDT. Methods: ALA penetration through excised normal human skin (NS) and AK lesions was evaluated using a cryostatic sectioning technique and radio-isotope counting following drug delivery using a novel, bioadhesive patch, loaded with 19, 38 or 50 mg/cm(2) ALA. Results: Distinct differences in ALA concentration with respect to depth between AK and NS samples were shown, particularly within the superficial layers of the tissue structure, down to a depth of 1.0 mm. Patch application times were shown to influence ALA concentrationsin tissue, but there was no clear correlation between ALA penetration in AK lesions taken from different body locations and from patients of different age. Similarly, the thickness of stratum corneum was not related to the ALA distribution profiles. Conclusions: Sizable variation in ALA concentration was a prominent feature of profiles through AK lesions, which may explain the variation of observed protoporphyrin IX production seen in the clinical implementation of AK PDT. That said, the results of this study show sufficient ALA penetration to a depth of 1.0 mm, which should be satisfactory for successful treatment of the majority of non-hyperkeratotic, hypertrophic AK using patch-based delivery methods.
机译:背景:在某些亚型的光化性角化病(AK)(例如肥大性和角化过度性病变)中,基于氨基乙酰丙酸(ALA)的光动力疗法(PDT)的反应率是可变的,这归因于所谓的ALA穿透力不足。给药后,详细的与深度相关的AK在AK中的空间ALA渗透情况将使人们更加了解原卟啉IX生物合成和随后的PDT之前可达到的浓度。方法:使用低温切片技术和载有19、38或50 mg / cm 2的新型生物粘附贴剂,在药物递送后通过冷冻切片技术和放射性同位素计数来评估ALA通过切除的正常人皮肤(NS)和AK病变的渗透率(2)翼。结果:在AK和NS样品之间,特别是在组织结构的浅层中,深度达到1.0 mm时,ALA浓度相对于深度存在明显差异。研究表明,贴剂的使用时间会影响组织中ALA的浓度,但在不同身体部位和不同年龄患者的AK病变中ALA渗透之间没有明显的相关性。同样,角质层的厚度与ALA分布图无关。结论:ALA浓度的显着变化是通过AK病变引起的轮廓的显着特征,这可以解释在AK PDT的临床实施中观察到的原卟啉IX产生的变化。就是说,这项研究的结果表明ALA穿透深度达到1.0毫米,这对于使用基于贴片的递送方法成功治疗大多数非角化过度,肥厚性AK来说应该是令人满意的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号